ABBV-744 T4697
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
ABBV-744 is a BDII-selective BET bromodomain inhibitor that inhibits BRD2/3/4. It is used in the research on inflammatory diseases, cancer, and AIDS.
CAS nr:
2138861-99-9
Purity:
98%
Molecular Weight:
491,55
SMILES:
CCNC(=O)c1cc2c(cn(C)c(=O)c2[nH]1)-c1cc(ccc1Oc1c(C)cc(F)cc1C)C(C)(C)O
Formula:
C28H30FN3O4
Pathway:
Proteases/Proteasome,Microbiology/Virology,Chromatin/Epigenetic
Target:
HIV Protease,HIV Protease,Epigenetic Reader Domain
